Chacko Jacob
PRESIDENT AND CEO
Chacko Jacob has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 17, 2025.
On the most recent filing, Chacko Jacob is listed as PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. Inside the rolling window, Chacko Jacob reported no open-market purchases and 1 open-market sale totaling $302K in ORIC.
Companies traded
Other insiders at ORIC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$302K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 6, 2025 | ORIC | Sale | $462K |
| Oct 1, 2025 | ORIC | Sale | $639K |
| Sep 30, 2025 | ORIC | Sale | $415K |
| Sep 22, 2025 | ORIC | Sale | $1.3M |
Frequently asked questions
How many SEC Form 4 filings has Chacko Jacob made?
Chacko Jacob has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Chacko Jacob trade?
Chacko Jacob has filed SEC Form 4 disclosures for 1 company, including ORIC.
When was Chacko Jacob's most recent SEC Form 4 filing?
Chacko Jacob's most recent SEC Form 4 filing on Tracefour is dated Dec 17, 2025.
What is Chacko Jacob's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Chacko Jacob is listed as PRESIDENT AND CEO.
What is Chacko Jacob's total buy and sell value in the current window?
Inside the rolling retention window, Chacko Jacob bought $0 and sold $302K based on SEC Form 4 filings.
What was Chacko Jacob's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 33,374 ORIC shares on 2025-12-16, worth $302K, per SEC Form 4 filings.